Oltmans Curtis Gale 4
4 · Fulcrum Therapeutics, Inc. · Filed Dec 7, 2020
Insider Transaction Report
Form 4
Oltmans Curtis Gale
Chief Legal Officer
Transactions
- Award
Stock Option (right to buy)
2020-12-03+153,600→ 153,600 totalExercise: $11.82Exp: 2030-12-02→ Common Stock (153,600 underlying)
Footnotes (1)
- [F1]This option was granted on December 3, 2020 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of November 30, 2020. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service.